Back to Journals » ImmunoTargets and Therapy
ImmunoTargets and Therapy
ISSN: 2253-1556

Editor-in-Chief: Professor Michael R Shurin
ImmunoTargets and Therapy is an international journal that aims to present and publish basic and clinical research on the aspects of immunology in health and disease. ImmunoTargets and Therapy is primarily focused on the immunological basis of disease and explores the evidence behind new and existing immunotherapies in terms of improving outcomes and, importantly, will seek to define their usage in terms of ultimate uptake and acceptance by the patient and health care professional.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (146)
- Volume 12, 2023 (5)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Latest articles:
- 5 records -
Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]
Wiggins S, Levit NA
ImmunoTargets and Therapy 2023, 12:77-78
Published Date: 25 May 2023
Association of Toll-like Receptors 1, 2, 4, 6, 8, 9 and 10 Genes Polymorphisms and Susceptibility to Pulmonary Tuberculosis in Sudanese Patients
Mhmoud NA
ImmunoTargets and Therapy 2023, 12:47-75
Published Date: 6 April 2023
Novel Immunotherapies for Myasthenia Gravis
Nair SS, Jacob S
ImmunoTargets and Therapy 2023, 12:25-45
Published Date: 4 April 2023
A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX
Zhu J, Li G, Zhang Z, Wang Y
ImmunoTargets and Therapy 2023, 12:17-23
Published Date: 19 February 2023
Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer
Wang X, Guo Z, Wu X, Chen D, Wang F, Yang L, Luo M, Wu S, Yang C, Huang L, Fu L
ImmunoTargets and Therapy 2023, 12:1-16
Published Date: 4 January 2023